AK

Ashutosh Kumar

Active Director Director DIN 08660976
DIN 08660976 First appointment Jan 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Ashutosh Kumar

Data last updated:

Ashutosh Kumar is a Director at Gaurisi Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Gaurisi Pharmaceuticals Private Limited reported revenue of ₹14 Lakh (FY 2022).

DIN 08660976
Primary Designation Director
Industry Trading
First Appointment 07 Jan 2020
Oldest Company Age 6 yrs
Largest company Gaurisi Pharmaceuticals Private Limited · ₹14 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jan 20202020₹14 Lakh (FY 2022)Active

Board colleagues of Ashutosh Kumar

Directorship timeline

Open interactive timeline →
Gaurisi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashutosh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashutosh Kumar

Ashutosh Kumar currently holds 1 directorship: Gaurisi Pharmaceuticals Private Limited (Director, since 07 Jan 2020, revenue ₹14 Lakh (FY 2022)).

Ashutosh Kumar was first appointed on 07 Jan 2020 as Director at Gaurisi Pharmaceuticals Private Limited.

The current boards of Ashutosh Kumar's companies include Ashish Pratap Singh (Gaurisi Pharmaceuticals Private Limited), Ravi Shankar Singh (Gaurisi Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available